Yoshiya Tanaka (Shigeru Iwata, Y Tanaka)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 278

Top Venues

Modern rheumatology

RMD open

Annals of the rheumatic diseases

Rheumatology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Yasuyuki Todoroki, Yoshiya Tanaka
Evolution of diagnostic criteria and new insights into clinical testing in mixed connective tissue disease; anti-survival motor neuron complex antibody as a novel marker of severity of the disease. Immunological medicine (2024)
Yurie Satoh-Kanda, Shingo Nakayamada, Yasuyuki Todoroki, Kaoru Yamagata, Aya Nawata, Hiroaki Tanaka, Shunpei Kosaka, Ryuichiro Kanda, Shan Yu, Yuya Fujita, Koshiro Sonomoto, Yoshiya Tanaka
Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus. RMD open 10 (2) (2024)
Zirui Zeng, Yasuhiro Yoshida, Duo Wang, Yuri Fujii, Mengyue Shen, Tatsuya Mimura, Yoshiya Tanaka
Inflammatory Cytokines and Chemokines Are Synergistically Induced in a ROS-Dependent Manner by a Co-Culture of Corneal Epithelial Cells and Neutrophil-like Cells in the Presence of Particulate Matter. Antioxidants (Basel, Switzerland) 13 (4) (2024)
Yuki Ishikawa, Nao Tanaka, Yoshihide Asano, Masanari Kodera, Yuichiro Shirai, Mitsuteru Akahoshi, Minoru Hasegawa, Takashi Matsushita, Kazuyoshi Saito, Sei-Ichiro Motegi, Hajime Yoshifuji, Ayumi Yoshizaki, Tomohiro Kohmoto, Kae Takagi, Akira Oka, Miho Kanda, Yoshihito Tanaka, Yumi Ito, Kazuhisa Nakano, Hiroshi Kasamatsu, Akira Utsunomiya, Akiko Sekiguchi, Hiroaki Niiro, Masatoshi Jinnin, Katsunari Makino, Takamitsu Makino, Hironobu Ihn, Motohisa Yamamoto, Chisako Suzuki, Hiroki Takahashi, Emi Nishida, Akimichi Morita, Toshiyuki Yamamoto, Manabu Fujimoto, Yuya Kondo, Daisuke Goto, Takayuki Sumida, Naho Ayuzawa, Hidetoshi Yanagida, Tetsuya Horita, Tatsuya Atsumi, Hirahito Endo, Yoshihito Shima, Atsushi Kumanogoh, Jun Hirata, Nao Otomo, Hiroyuki Suetsugu, Yoshinao Koike, Kohei Tomizuka, Soichiro Yoshino, Xiaoxi Liu, Shuji Ito, Keiko Hikino, Akari Suzuki, Yukihide Momozawa, Shiro Ikegawa, Yoshiya Tanaka, Osamu Ishikawa, Kazuhiko Takehara, Takeshi Torii, Shinichi Sato, Yukinori Okada, Tsuneyo Mimori, Fumihiko Matsuda, Koichi Matsuda, Tiffany Amariuta, Issei Imoto, Keitaro Matsuo, Masataka Kuwana, Yasushi Kawaguchi, Koichiro Ohmura, Chikashi C Terao
GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region. Nature communications 15 (1) (2024)
Yoshiya Tanaka, Satoshi Soen, Shintaro Hirata, Yosuke Okada, Saeko Fujiwara, Ikuko Tanaka, Yuriko Kitajima, Takuo Kubota, Kosuke Ebina, Yuichi Takashi, Reiko Inoue, Mika Yamauchi, Naoaki Okubo, Masanobu Ueno, Yasuhisa Ohata, Nobuaki Ito, Keiichi Ozono, Hisanori Nakayama, Masakazu Terauchi, Sakae Tanaka, Seiji Fukumoto
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis. Journal of bone and mineral metabolism 42 (2) (2024)
Tayyeba Khursheed, Pavel V Ovseiko, Sarah Dyball, Ran Nakashima, Ana Maria Arredondo Gonzalez, Alejandra Babini, Asgar Ali Kalla, Catherine Hill, Debashish Danda, Dzifa Dey, Lisa Traboco, Elena Nikiphorou, Ghita Harifi, Humeira Badshah, Ihsane Hmamouchi, Joan Marie Von Feldt, Júlia Boechat Farani, Laura Andreoli, Mariana Peixoto Guimarães, Carlos Enrique Toro Gutiérrez, Cristiana Sieiro Santos, Christina Duftner, Deshiré Alpizar-Rodriguez, Nelly Ziadé, Penélope Esther Palominos, Syed Atiqul Haq, Wilson Bautista Molano, Yoshiya Tanaka, Laure Gossec, Vikas Agarwal, Grace C Wright, Laura C Coates, Latika Gupta, null null
Coalition for Health and Gender Equity (CHANGE)-a protocol for a global cross-sectional survey of health and gender equity in rheumatology. Rheumatology advances in practice 8 (2) (2024)
Eric F Morand, Joseph F Merola, Yoshiya Tanaka, Dafna D Gladman, Roy M Fleischmann
TYK2: an emerging therapeutic target in rheumatic disease. Nature reviews. Rheumatology 20 (4) (2024)
Eric F Morand, Joseph F Merola, Yoshiya Tanaka, Dafna D Gladman, Roy M Fleischmann
TYK2: an emerging therapeutic target in rheumatic disease. Nature reviews. Rheumatology 20 (4) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Yasuhiro Katsumata, Eisuke Inoue, Masayoshi Harigai, Jiacai Cho, Worawit Louthrenoo, Alberta Y Hoi, Vera Golder, Chak Sing Lau, Aisha Lateef, Yi-Hsing Chen, Shue-Fen Luo, Yeong-Jian Jan Wu, Laniyati Hamijoyo, Zhanguo Li, Sargunan Sockalingam, Sandra Navarra, Leonid Zamora, Yanjie Hao, Zhuoli Zhang, Madelynn Chan, Shereen Oon, Kristine Ng, Jun Kikuchi, Tsutomu Takeuchi, Fiona Goldblatt, Sean O'Neill, Nicola Tugnet, Annie Hui Nee Law, Sang-Cheol Bae, Yoshiya Tanaka, Naoaki Ohkubo, Sunil Kumar, Rangi Kandane-Rathnayake, Mandana Nikpour, Eric F Morand, null null
Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study. Annals of the rheumatic diseases (2024)
Masashi Funada, Yusuke Miyazaki, Shingo Nakayamada, Koshiro Sonomoto, Yasuyuki Todoroki, Ippei Miyagawa, Hiroaki Tanaka, Yoshiya Tanaka
CT informs detection and treatment options in rheumatoid arthritis complicated by pulmonary non-tuberculous mycobacterial disease from the FIRST registry. RMD open 10 (2) (2024)
Yoshiya Tanaka, Tsutomu Takeuchi, Hernan Valdez, Mark Collinge, Samuel H Zwillich, Shigeyuki Toyoizumi, Kenneth Kwok, Tomohiro Hirose
Relationship between lymphocyte count and risk of infection in Japanese rheumatoid arthritis patients treated with tofacitinib. Modern rheumatology (2024)
Naoaki Ohkubo, Yusuke Miyazaki, Shingo Nakayamada, Shunsuke Fukuyo, Yoshino Inoue, Yurie Satoh-Kanda, Hiroaki Tanaka, Yasuyuki Todoroki, Hiroko Miyata, Atsushi Nagayasu, Masashi Funada, Hiroki Kobayashi, Hidenori Sakai, Shumpei Kosaka, Satsuki Matsunaga, Yukiko Tomoyose, Hirotsugu Nohara, Yoshiya Tanaka
Efficacy and Safety of Biologics in Polymyalgia Rheumatica: A Retrospective Study. Rheumatology and therapy (2024)
Masashi Funada, Yusuke Miyazaki, Shingo Nakayamada, Koshiro Sonomoto, Yasuyuki Todoroki, Ippei Miyagawa, Hiroaki Tanaka, Yoshiya Tanaka
CT informs detection and treatment options in rheumatoid arthritis complicated by pulmonary non-tuberculous mycobacterial disease from the FIRST registry. RMD open 10 (2) (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Yoshiya Tanaka, Yusuke Miyazaki, Masafumi Kawanishi, Hironori Yamasaki, Tsutomu Takeuchi
Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritis. RMD open 10 (3) (2024)
Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, Atsushi Nagayasu, Shingo Nakayamada, Yoshiya Tanaka
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry. Rheumatology and therapy 11 (3) (2024)
Yasuyuki Todoroki, Yoshiya Tanaka
Evolution of diagnostic criteria and new insights into clinical testing in mixed connective tissue disease; anti-survival motor neuron complex antibody as a novel marker of severity of the disease. Immunological medicine 47 (2) (2024)
Yoshiya Tanaka, Satoshi Soen, Shintaro Hirata, Yosuke Okada, Saeko Fujiwara, Ikuko Tanaka, Yuriko Kitajima, Takuo Kubota, Kosuke Ebina, Yuichi Takashi, Reiko Inoue, Mika Yamauchi, Naoaki Okubo, Masanobu Ueno, Yasuhisa Ohata, Nobuaki Ito, Keiichi Ozono, Hisanori Nakayama, Masakazu Terauchi, Sakae Tanaka, Seiji Fukumoto
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis. Journal of bone and mineral metabolism (2024)
Yoshiya Tanaka, Kei Ikeda, Yuko Kaneko, Naoki Ishiguro, Tsutomu Takeuchi
Why does malaise/fatigue occur? Underlying mechanisms and potential relevance to treatments in rheumatoid arthritis. Expert review of clinical immunology 20 (5) (2024)
Eric F Morand, Joseph F Merola, Yoshiya Tanaka, Dafna D Gladman, Roy M Fleischmann
TYK2: an emerging therapeutic target in rheumatic disease. Nature reviews. Rheumatology (2024)
Nami Okamoto, Tatsuya Atsumi, Michiaki Takagi, Nobunori Takahashi, Tsutomu Takeuchi, Naoto Tamura, Atsuo Nakajima, Ayako Nakajima, Takao Fujii, Hiroaki Matsuno, Taeko Ishii, Naoto Tsujimoto, Atsushi Nishikawa, Machiko Minatoya, Yoshiya Tanaka, Masataka Kuwana
Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case post-marketing surveillance study. Modern rheumatology (2024)
Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, Atsushi Nagayasu, Shingo Nakayamada, Yoshiya Tanaka
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry. Rheumatology and therapy 11 (3) (2024)
Masashi Funada, Yusuke Miyazaki, Shingo Nakayamada, Koshiro Sonomoto, Yasuyuki Todoroki, Ippei Miyagawa, Hiroaki Tanaka, Yoshiya Tanaka
CT informs detection and treatment options in rheumatoid arthritis complicated by pulmonary non-tuberculous mycobacterial disease from the FIRST registry. RMD open 10 (2) (2024)
Tayyeba Khursheed, Pavel V Ovseiko, Sarah Dyball, Ran Nakashima, Ana Maria Arredondo Gonzalez, Alejandra Babini, Asgar Ali Kalla, Catherine Hill, Debashish Danda, Dzifa Dey, Lisa Traboco, Elena Nikiphorou, Ghita Harifi, Humeira Badshah, Ihsane Hmamouchi, Joan Marie Von Feldt, Júlia Boechat Farani, Laura Andreoli, Mariana Peixoto Guimarães, Carlos Enrique Toro Gutiérrez, Cristiana Sieiro Santos, Christina Duftner, Deshiré Alpizar-Rodriguez, Nelly Ziadé, Penélope Esther Palominos, Syed Atiqul Haq, Wilson Bautista Molano, Yoshiya Tanaka, Laure Gossec, Vikas Agarwal, Grace C Wright, Laura C Coates, Latika Gupta, null null
Coalition for Health and Gender Equity (CHANGE)-a protocol for a global cross-sectional survey of health and gender equity in rheumatology. Rheumatology advances in practice 8 (2) (2024)
Yoshiya Tanaka, Satoshi Soen, Shintaro Hirata, Yosuke Okada, Saeko Fujiwara, Ikuko Tanaka, Yuriko Kitajima, Takuo Kubota, Kosuke Ebina, Yuichi Takashi, Reiko Inoue, Mika Yamauchi, Naoaki Okubo, Masanobu Ueno, Yasuhisa Ohata, Nobuaki Ito, Keiichi Ozono, Hisanori Nakayama, Masakazu Terauchi, Sakae Tanaka, Seiji Fukumoto
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis. Journal of bone and mineral metabolism 42 (2) (2024)
Yoshiya Tanaka, Kei Ikeda, Yuko Kaneko, Naoki Ishiguro, Tsutomu Takeuchi
Why does malaise/fatigue occur? Underlying mechanisms and potential relevance to treatments in rheumatoid arthritis. Expert review of clinical immunology (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Yoshiya Tanaka, Kei Ikeda, Yuko Kaneko, Naoki Ishiguro, Tsutomu Takeuchi
Why does malaise/fatigue occur? Underlying mechanisms and potential relevance to treatments in rheumatoid arthritis. Expert review of clinical immunology 20 (5) (2024)
Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, Atsushi Nagayasu, Shingo Nakayamada, Yoshiya Tanaka
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry. Rheumatology and therapy 11 (3) (2024)
Yoshiya Tanaka, Yusuke Miyazaki, Masafumi Kawanishi, Hironori Yamasaki, Tsutomu Takeuchi
Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritis. RMD open 10 (3) (2024)
Yoshiya Tanaka, Atsushi Kumanogoh, Tatsuya Atsumi, Tomonori Ishii, Fumitoshi Tago, Mari Aoki, Shintaro Yamamuro, Shizuo Akira
Safety, pharmacokinetics, biomarker response and efficacy of E6742: a dual antagonist of Toll-like receptors 7 and 8, in a first in patient, randomised, double-blind, phase I/II study in systemic lupus erythematosus. RMD open 10 (3) (2024)
Yuki Ishikawa, Nao Tanaka, Yoshihide Asano, Masanari Kodera, Yuichiro Shirai, Mitsuteru Akahoshi, Minoru Hasegawa, Takashi Matsushita, Kazuyoshi Saito, Sei-Ichiro Motegi, Hajime Yoshifuji, Ayumi Yoshizaki, Tomohiro Kohmoto, Kae Takagi, Akira Oka, Miho Kanda, Yoshihito Tanaka, Yumi Ito, Kazuhisa Nakano, Hiroshi Kasamatsu, Akira Utsunomiya, Akiko Sekiguchi, Hiroaki Niiro, Masatoshi Jinnin, Katsunari Makino, Takamitsu Makino, Hironobu Ihn, Motohisa Yamamoto, Chisako Suzuki, Hiroki Takahashi, Emi Nishida, Akimichi Morita, Toshiyuki Yamamoto, Manabu Fujimoto, Yuya Kondo, Daisuke Goto, Takayuki Sumida, Naho Ayuzawa, Hidetoshi Yanagida, Tetsuya Horita, Tatsuya Atsumi, Hirahito Endo, Yoshihito Shima, Atsushi Kumanogoh, Jun Hirata, Nao Otomo, Hiroyuki Suetsugu, Yoshinao Koike, Kohei Tomizuka, Soichiro Yoshino, Xiaoxi Liu, Shuji Ito, Keiko Hikino, Akari Suzuki, Yukihide Momozawa, Shiro Ikegawa, Yoshiya Tanaka, Osamu Ishikawa, Kazuhiko Takehara, Takeshi Torii, Shinichi Sato, Yukinori Okada, Tsuneyo Mimori, Fumihiko Matsuda, Koichi Matsuda, Tiffany Amariuta, Issei Imoto, Keitaro Matsuo, Masataka Kuwana, Yasushi Kawaguchi, Koichiro Ohmura, Chikashi C Terao
GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region. Nature communications 15 (1) (2024)
Phillip J Mease, Joseph Frank Merola, Yoshiya Tanaka, Laure Gossec, Iain B McInnes, Christopher T Ritchlin, Robert B M Landewe, Akihiko Asahina, Barbara Ink, Andrea Heinrichs, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Laura C Coates
Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies. Rheumatology and therapy (2024)
Yoshiya Tanaka, Yusuke Miyazaki, Masafumi Kawanishi, Hironori Yamasaki, Tsutomu Takeuchi
Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritis. RMD open 10 (3) (2024)
Yasuyuki Todoroki, Yoshiya Tanaka
The immune health metric as an indicator of health and disease. Nature reviews. Rheumatology (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, Atsushi Nagayasu, Shingo Nakayamada, Yoshiya Tanaka
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry. Rheumatology and therapy (2024)
Yasuhiro Katsumata, Eisuke Inoue, Masayoshi Harigai, Jiacai Cho, Worawit Louthrenoo, Alberta Y Hoi, Vera Golder, Chak Sing Lau, Aisha Lateef, Yi-Hsing Chen, Shue-Fen Luo, Yeong-Jian Jan Wu, Laniyati Hamijoyo, Zhanguo Li, Sargunan Sockalingam, Sandra Navarra, Leonid Zamora, Yanjie Hao, Zhuoli Zhang, Madelynn Chan, Shereen Oon, Kristine Ng, Jun Kikuchi, Tsutomu Takeuchi, Fiona Goldblatt, Sean O'Neill, Nicola Tugnet, Annie Hui Nee Law, Sang-Cheol Bae, Yoshiya Tanaka, Naoaki Ohkubo, Sunil Kumar, Rangi Kandane-Rathnayake, Mandana Nikpour, Eric F Morand, null null
Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study. Annals of the rheumatic diseases 83 (8) (2024)
Yasuhiro Katsumata, Eisuke Inoue, Masayoshi Harigai, Jiacai Cho, Worawit Louthrenoo, Alberta Y Hoi, Vera Golder, Chak Sing Lau, Aisha Lateef, Yi-Hsing Chen, Shue-Fen Luo, Yeong-Jian Jan Wu, Laniyati Hamijoyo, Zhanguo Li, Sargunan Sockalingam, Sandra Navarra, Leonid Zamora, Yanjie Hao, Zhuoli Zhang, Madelynn Chan, Shereen Oon, Kristine Ng, Jun Kikuchi, Tsutomu Takeuchi, Fiona Goldblatt, Sean O'Neill, Nicola Tugnet, Annie Hui Nee Law, Sang-Cheol Bae, Yoshiya Tanaka, Naoaki Ohkubo, Sunil Kumar, Rangi Kandane-Rathnayake, Mandana Nikpour, Eric F Morand, null null
Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study. Annals of the rheumatic diseases 83 (8) (2024)
Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, Atsushi Nagayasu, Shingo Nakayamada, Yoshiya Tanaka
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry. Rheumatology and therapy 11 (3) (2024)
Katsuhide Kusaka, Shingo Nakayamada, Kentaro Hanami, Aya Nawata, Yoshiya Tanaka
A Case of Immunoglobulin G4-related Disease Complicated by Atopic Dermatitis Responsive to Upadacitinib Treatment. Modern rheumatology case reports (2024)
Yoshiya Tanaka, Tsutomu Takeuchi, Yoshiaki Morita, Yuichiro Kaneko, Wataru Terada
Safety and effectiveness of peficitinib 100 mg/day in patients achieving clinical remission from a long-term open-label extension study in Japan, Korea, and Taiwan (RAJ2). Modern rheumatology 34 (5) (2024)
Joan T Merrill, Yoshiya Tanaka, David D'Cruz, Karina Vila-Rivera, Daniel Siri, Xiaofeng Zeng, Amit Saxena, Martin Aringer, Kristin M D'Silva, Ling Cheng, Mohamed-Eslam F Mohamed, Lucia Siovitz, Sumit Bhatnagar, Marie-Claude Gaudreau, Thao T Doan, Alan Friedman
Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Gerd-Rüdiger R Burmester, Jacques-Eric Gottenberg, Roberto Felice Caporali, Kevin L Winthrop, Yoshiya Tanaka, Edmund V Ekoka Omoruyi, Vijay Rajendran, Paul Van Hoek, Katrien Van Beneden, Tsutomu Takeuchi, René Westhovens, Daniel Aletaha
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years. Annals of the rheumatic diseases 83 (9) (2024)
Vera Golder, Rangi Kandane-Rathnayake, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue-Fen Luo, Yeong-Jian J Wu, Sandra V Navarra, Leonid D Zamora, Zhan-Guo Li, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi Harigai, Yanjie Hao, Zhuoli Zhang, B M D B Basnayake, Madelynn Chan, Jun Kikuchi, Tsutomu Takeuchi, Sang-Cheol Bae, Shereen Oon, Sean O'Neill, Fiona Goldblatt, Kristine Pek Ling Ng, Annie Law, Nicola Tugnet, Sunil Kumar, Cherica A Tee, Michael Lucas Tee, Naoaki Ohkubo, Yoshiya Tanaka, Wallace Chak Sing Lau, Mandana Nikpour, Alberta Y Hoi, Eric F Morand, null null
Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State In Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus. The Journal of rheumatology (2024)
Yurie Satoh-Kanda, Shingo Nakayamada, Yasuyuki Todoroki, Kaoru Yamagata, Aya Nawata, Hiroaki Tanaka, Shunpei Kosaka, Ryuichiro Kanda, Shan Yu, Yuya Fujita, Koshiro Sonomoto, Yoshiya Tanaka
Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus. RMD open 10 (2) (2024)
Vera Golder, Rangi Kandane-Rathnayake, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue-Fen Luo, Yeong-Jian J Wu, Sandra V Navarra, Leonid D Zamora, Zhan-Guo Li, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi Harigai, Yanjie Hao, Zhuoli Zhang, B M D B Basnayake, Madelynn Chan, Jun Kikuchi, Tsutomu Takeuchi, Sang-Cheol Bae, Shereen Oon, Sean O'Neill, Fiona Goldblatt, Kristine Pek Ling Ng, Annie Law, Nicola Tugnet, Sunil Kumar, Cherica A Tee, Michael Lucas Tee, Naoaki Ohkubo, Yoshiya Tanaka, Wallace Chak Sing Lau, Mandana Nikpour, Alberta Y Hoi, Eric F Morand, null null
Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus. The Journal of rheumatology 51 (8) (2024)
Yoshiya Tanaka, Toshiya Takahashi, Hubert van Hoogstraten, Naoto Kato, Hideto Kameda
The effects of sarilumab as monotherapy and in combination with non-methotrexate disease-modifying anti-rheumatic drugs on unacceptable pain in patients with rheumatoid arthritis: a post-hoc analysis of the HARUKA phase 3 study. Modern rheumatology (2024)
Gerd-Rüdiger R Burmester, Jacques-Eric Gottenberg, Roberto Felice Caporali, Kevin L Winthrop, Yoshiya Tanaka, Edmund V Ekoka Omoruyi, Vijay Rajendran, Paul Van Hoek, Katrien Van Beneden, Tsutomu Takeuchi, René Westhovens, Daniel Aletaha
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years. Annals of the rheumatic diseases (2024)
Yoshiya Tanaka, Satoshi Soen, Shintaro Hirata, Yosuke Okada, Saeko Fujiwara, Ikuko Tanaka, Yuriko Kitajima, Takuo Kubota, Kosuke Ebina, Yuichi Takashi, Reiko Inoue, Mika Yamauchi, Naoaki Okubo, Masanobu Ueno, Yasuhisa Ohata, Nobuaki Ito, Keiichi Ozono, Hisanori Nakayama, Masakazu Terauchi, Sakae Tanaka, Seiji Fukumoto
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis. Journal of bone and mineral metabolism 42 (2) (2024)
Yasuyuki Todoroki, Yoshiya Tanaka
Evolution of diagnostic criteria and new insights into clinical testing in mixed connective tissue disease; anti-survival motor neuron complex antibody as a novel marker of severity of the disease. Immunological medicine 47 (2) (2024)
Yoshiya Tanaka, Kei Ikeda, Yuko Kaneko, Naoki Ishiguro, Tsutomu Takeuchi
Why does malaise/fatigue occur? Underlying mechanisms and potential relevance to treatments in rheumatoid arthritis. Expert review of clinical immunology (2024)
Yoshiya Tanaka, Tsutomu Takeuchi, Yoshiaki Morita, Yuichiro Kaneko, Wataru Terada
Safety and effectiveness of peficitinib 100 mg/day in patients achieving clinical remission from a long-term open-label extension study in Japan, Korea, and Taiwan (RAJ2). Modern rheumatology 34 (5) (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Zirui Zeng, Yasuhiro Yoshida, Duo Wang, Yuri Fujii, Mengyue Shen, Tatsuya Mimura, Yoshiya Tanaka
Inflammatory Cytokines and Chemokines Are Synergistically Induced in a ROS-Dependent Manner by a Co-Culture of Corneal Epithelial Cells and Neutrophil-like Cells in the Presence of Particulate Matter. Antioxidants (Basel, Switzerland) 13 (4) (2024)
Yurie Satoh-Kanda, Shingo Nakayamada, Yasuyuki Todoroki, Kaoru Yamagata, Aya Nawata, Hiroaki Tanaka, Shunpei Kosaka, Ryuichiro Kanda, Shan Yu, Yuya Fujita, Koshiro Sonomoto, Yoshiya Tanaka
Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus. RMD open 10 (2) (2024)
Yurie Satoh-Kanda, Shingo Nakayamada, Yasuyuki Todoroki, Kaoru Yamagata, Aya Nawata, Hiroaki Tanaka, Shunpei Kosaka, Ryuichiro Kanda, Shan Yu, Yuya Fujita, Koshiro Sonomoto, Yoshiya Tanaka
Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus. RMD open 10 (2) (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases (2024)
Eric F Morand, Joseph F Merola, Yoshiya Tanaka, Dafna D Gladman, Roy M Fleischmann
TYK2: an emerging therapeutic target in rheumatic disease. Nature reviews. Rheumatology (2024)
Gerd-Rüdiger R Burmester, Jacques-Eric Gottenberg, Roberto Felice Caporali, Kevin L Winthrop, Yoshiya Tanaka, Edmund V Ekoka Omoruyi, Vijay Rajendran, Paul Van Hoek, Katrien Van Beneden, Tsutomu Takeuchi, René Westhovens, Daniel Aletaha
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years. Annals of the rheumatic diseases 83 (9) (2024)
Nao Tsugita, Ippei Miyagawa, Shingo Nakayamada, Aya Nawata, Shumpei Kosaka, Masanobu Ueno, Yoshiya Tanaka
Epstein-Barr Virus-Encoded RNA-Positive Lymphocytes in Bone Marrow and Lymph Nodes in an Autopsy Case of TAFRO Syndrome. Modern rheumatology case reports (2024)
Laure Gossec, Andreas Kerschbaumer, Ricardo Jorge de Oliveira Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd-Rüdiger R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, AnnaMaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Phillip J Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Larissa Valor-Méndez, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée Mfm van der Heijde, Josef S Smolen
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Annals of the rheumatic diseases 83 (6) (2024)
Ken-Ei Sada, Takako Miyamae, Kayoko Kaneko, Sakiko Isojima, Kunihiro Ichinose, Masakazu Matsushita, Kenji Oku, Yasunori Iwata, Keishi Fujio, Atsuko Murashima, Yoshiya Tanaka, Ayako Nakajima
Effects of cyclophosphamide administration on ovarian dysfunction in pediatric patients with connective tissue diseases: A systematic scoping review. Modern rheumatology (2024)
Yuki Ishikawa, Nao Tanaka, Yoshihide Asano, Masanari Kodera, Yuichiro Shirai, Mitsuteru Akahoshi, Minoru Hasegawa, Takashi Matsushita, Kazuyoshi Saito, Sei-Ichiro Motegi, Hajime Yoshifuji, Ayumi Yoshizaki, Tomohiro Kohmoto, Kae Takagi, Akira Oka, Miho Kanda, Yoshihito Tanaka, Yumi Ito, Kazuhisa Nakano, Hiroshi Kasamatsu, Akira Utsunomiya, Akiko Sekiguchi, Hiroaki Niiro, Masatoshi Jinnin, Katsunari Makino, Takamitsu Makino, Hironobu Ihn, Motohisa Yamamoto, Chisako Suzuki, Hiroki Takahashi, Emi Nishida, Akimichi Morita, Toshiyuki Yamamoto, Manabu Fujimoto, Yuya Kondo, Daisuke Goto, Takayuki Sumida, Naho Ayuzawa, Hidetoshi Yanagida, Tetsuya Horita, Tatsuya Atsumi, Hirahito Endo, Yoshihito Shima, Atsushi Kumanogoh, Jun Hirata, Nao Otomo, Hiroyuki Suetsugu, Yoshinao Koike, Kohei Tomizuka, Soichiro Yoshino, Xiaoxi Liu, Shuji Ito, Keiko Hikino, Akari Suzuki, Yukihide Momozawa, Shiro Ikegawa, Yoshiya Tanaka, Osamu Ishikawa, Kazuhiko Takehara, Takeshi Torii, Shinichi Sato, Yukinori Okada, Tsuneyo Mimori, Fumihiko Matsuda, Koichi Matsuda, Tiffany Amariuta, Issei Imoto, Keitaro Matsuo, Masataka Kuwana, Yasushi Kawaguchi, Koichiro Ohmura, Chikashi C Terao
GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region. Nature communications 15 (1) (2024)
Masashi Funada, Shingo Nakayamada, Shunsuke Fukuyo, Yasuyuki Todoroki, Aya Nawata, Yuya Fujita, Yoshiya Tanaka
A case of Buerger's disease with vasculopathy and skin fibrosis requiring differential diagnosis from systemic sclerosis. Modern rheumatology case reports (2024)
Yanjie Hao, Dylan Hansen, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue-Fen Luo, Yeong-Jian Jan Wu, Sandra V Navarra, Leonid Zamora, Zhanguo Li, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi Harigai, Zhuoli Zhang, Madelynn Chan, Jun Kikuchi, Tsutomu Takeuchi, Sang-Cheol Bae, Fiona Goldblatt, Sean O'Neill, Kristine Ng, B M D B Basnayake, Nicola Tugnet, Yoshiya Tanaka, Wallace Chak Sing Lau, Ning Li, Vera Golder, Alberta Y Hoi, Rangi Kandane-Rathnayake, Eric F Morand, Shereen Oon, Mandana Nikpour
Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosus. Lupus science & medicine 11 (2) (2024)
Eric F Morand, Joseph F Merola, Yoshiya Tanaka, Dafna D Gladman, Roy M Fleischmann
TYK2: an emerging therapeutic target in rheumatic disease. Nature reviews. Rheumatology 20 (4) (2024)
Hidenori Sakai, Yusuke Miyazaki, Shingo Nakayamada, Yasuyuki Todoroki, Kentaro Hanami, Shunsuke Fukuyo, Ayako Yamaguchi, Ippei Miyagawa, Masanobu Ueno, Hiroaki Tanaka, Yasuyuki Todoroki, Naoaki Ohkubo, Masashi Funada, Satsuki Matsunaga, Yoshiya Tanaka
Efficacy, safety, and optimal intervention of belimumab for proliferative lupus nephritis patients in real-world settings: LOOPS registry. Rheumatology (Oxford, England) (2024)
Yoshiya Tanaka, Toshiya Takahashi, Hubert van Hoogstraten, Naoto Kato, Hideto Kameda
Efficacy and safety of sarilumab in patients with rheumatoid arthritis stratified by age (<65 and ≥65 years): A post-hoc analysis of Japanese phase 3 clinical trials. Modern rheumatology (2024)
Yoshiya Tanaka, Satoshi Soen, Shintaro Hirata, Yosuke Okada, Saeko Fujiwara, Ikuko Tanaka, Yuriko Kitajima, Takuo Kubota, Kosuke Ebina, Yuichi Takashi, Reiko Inoue, Mika Yamauchi, Naoaki Okubo, Masanobu Ueno, Yasuhisa Ohata, Nobuaki Ito, Keiichi Ozono, Hisanori Nakayama, Masakazu Terauchi, Sakae Tanaka, Seiji Fukumoto
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis. Journal of bone and mineral metabolism 42 (2) (2024)
Laura C Coates, Robert B M Landewe, Iain B McInnes, Phillip J Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D Gladman, Laure Gossec, Ana Maria Orbai, Alice B Gottlieb, Richard B Warren, Barbara Ink, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Joseph F Merola
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL. RMD open 10 (1) (2024)
Iain B McInnes, Phillip J Mease, Yoshiya Tanaka, Laure Gossec, M Elaine Husni, Lars Erik Kristensen, Richard B Warren, Barbara Ink, Rajan Bajracharya, Jason Coarse, Alice B Gottlieb
Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 Studies. ACR open rheumatology (2024)
Yoshiya Tanaka, Kishimoto Mitsumasa, Koshiro Sonomoto, Koichi Amano, Masayoshi Harigai, Alina Onofrei, Jacqueline O'Brien, Zachary R Margolin, Christine Barr, Yasushi Mizuno, Ekta Agarwal, Naonobu Sugiyama, Hisashi Yamanaka
Methotrexate, Tofacitinib, and Biologic Disease-Modifying Antirheumatic Drug Safety and Effectiveness Among Patients with Rheumatoid Arthritis in Japan: CorEvitas Registry Observational Study. Rheumatology and therapy (2024)
Vera Golder, Rangi Kandane-Rathnayake, Worawit Louthrenoo, Yi-Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue-Fen Luo, Yeong-Jian J Wu, Sandra V Navarra, Leonid D Zamora, Zhan-Guo Li, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi Harigai, Yanjie Hao, Zhuoli Zhang, B M D B Basnayake, Madelynn Chan, Jun Kikuchi, Tsutomu Takeuchi, Sang-Cheol Bae, Shereen Oon, Sean O'Neill, Fiona Goldblatt, Kristine Pek Ling Ng, Annie Law, Nicola Tugnet, Sunil Kumar, Cherica A Tee, Michael Lucas Tee, Naoaki Ohkubo, Yoshiya Tanaka, Wallace Chak Sing Lau, Mandana Nikpour, Alberta Y Hoi, Eric F Morand, null null
Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus. The Journal of rheumatology 51 (8) (2024)
Joan T Merrill, Yoshiya Tanaka, David D'Cruz, Karina Vila-Rivera, Daniel Siri, Xiaofeng Zeng, Amit Saxena, Martin Aringer, Kristin M D'Silva, Ling Cheng, Mohamed-Eslam F Mohamed, Lucia Siovitz, Sumit Bhatnagar, Marie-Claude Gaudreau, Thao T Doan, Alan Friedman
Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Yoshiya Tanaka
What are the hot topics in Japanese rheumatology? Go above and beyond. RMD open 9 (1) (2023)
Yoshiya Tanaka
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia. Inflammation and regeneration 43 (1) (2023)
Yoshiya Tanaka, Atsuko Murashima, Tatsuya Atsumi, Hiroaki Dobashi, Yohko Murakawa, Shigeki Momohara, Haruna Kawaguchi, Shinji Tanigaki, Shintaro Makino, Shigeru Saito
The management of women of child-bearing age with rheumatoid arthritis: an expert report. Expert review of clinical immunology (2023)
Tsutomu Takeuchi, Sakae Tanaka, Mitsuru Murata, Yoshiya Tanaka
Irreversible covalent Bruton's tyrosine kinase inhibitor, TAS5315 versus placebo in rheumatoid arthritis patients with inadequate response to methotrexate: a randomised, double-blind, phase IIa trial. Annals of the rheumatic diseases (2023)
Hisashi Yamanaka, Kishimoto Mitsumasa, Nobuo Nishijima, Katsuhisa Yamashita, Junnosuke Matsushima, Jacqueline O'Brien, Taylor Blachley, Melissa Eliot, Zachary Margolin, Swapna S Dave, Yoshiya Tanaka
Socioeconomic impact of treatment with biological disease-modifying antirheumatic drugs in Japanese patients with rheumatoid arthritis. Modern rheumatology (2023)
Cory Perugino, Emma L Culver, Arezou Khosroshahi, Wen Zhang, Emanuel Della-Torre, Kazuichi Okazaki, Yoshiya Tanaka, Matthias Löhr, Nicolas Schleinitz, Judith Falloon, Dewei She, Daniel Cimbora, John H Stone
Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial. Rheumatology and therapy (2023)
Yasuyuki Todoroki, Yusuke Miyazaki, Yasuyuki Todoroki, Atsushi Nagayasu, Ryuichiro Kanda, Takafumi Aritomi, Satsuki Matsunaga, Masanobu Ueno, Ippei Miyagawa, Koshiro Sonomoto, Kentaro Hanami, Shingo Nakayamada, Yoshiya Tanaka
Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry. Rheumatology and therapy (2023)
Shingo Nakayamada, Yoshiya Tanaka
Immune Phenotype as a Biomarker for Systemic Lupus Erythematosus. Biomolecules 13 (6) (2023)
Yoshiya Tanaka, Tsutomu Takeuchi, Yoshiaki Morita, Yuichiro Kaneko, Wataru Terada
Safety and effectiveness of peficitinib 100 mg/day in patients achieving clinical remission from a long-term open-label extension study in Japan, Korea, and Taiwan (RAJ2). Modern rheumatology (2023)
Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, Martin Aringer, Laurent Arnaud, Sang-Cheol Bae, John Boletis, Ian N Bruce, Ricard Cervera, Andrea Doria, Thomas Dörner, Richard A Furie, Dafna D Gladman, Frederic A Houssiau, Luís Sousa Inês, David R W Jayne, Marios Kouloumas, László Kovács, Chi Chiu Mok, Eric F Morand, Gabriella Moroni, Marta Mosca, Johanna Mucke, Chetan B Mukhtyar, György Nagy, Sandra Navarra, Ioannis Parodis, José M Pego-Reigosa, Michelle A Petri, Bernardo A Pons-Estel, Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Yoshiya Tanaka, Maria G G Tektonidou, Y K Onno Teng, Angela Tincani, Edward M Vital, Ronald F Van Vollenhoven, Chris Wincup, George K Bertsias, Dimitrios T Boumpas
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Annals of the rheumatic diseases (2023)
Yoshiya Tanaka, Tsutomu Takeuchi, Derek Haaland, Stephen Hall, Güzide Nevsun İnanç, Zhanguo Li, Ricardo Machado Xavier, Carlos Cara, Nicola Tilt, Peter C Taylor
Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials. International journal of rheumatic diseases (2023)
Peter C Taylor, Cedric Laedermann, Rieke Alten, Eugen Feist, Ernest Choy, Ewa Haladyj, Inmaculada De La Torre, Pascal Richette, Axel Finckh, Yoshiya Tanaka
A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience. Journal of clinical medicine 12 (13) (2023)
Gerd-Rüdiger R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Phillip J Mease, Emma Guttman-Yassky
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD open 9 (1) (2023)
Shingo Nakayamada, Yoshiya Tanaka
Novel JAK inhibitors under investigation for systemic lupus erythematosus: - where are we now? Expert opinion on investigational drugs (2023)
Chun Wu, Yanhua Hu, Peter Schafer, Sean E Connolly, Robert Wong, Signe Holm Nielsen, Anne-Christine Bay-Jensen, Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Clifton O Bingham, Thomas Wj Huizinga, Roy M Fleischmann, Jinqi Liu
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis. RMD open 8 (2) (2023)
Yoshiya Tanaka, Fumitoshi Tago, Naoto Yamakawa, Mari Aoki, Takuya Yagi, Shizuo Akira
A new therapeutic target for systemic lupus erythematosus: the current landscape for drug development of a toll-like receptor 7/8 antagonist through academia-industry-government collaboration. Immunological medicine (2023)
Yoshiya Tanaka, Mark C Genovese, Hironori Matsushima
Long-Term Safety, Efficacy, and Patient-Centered Outcomes of Filgotinib in the Treatment of Rheumatoid Arthritis: Current Perspectives. Patient preference and adherence 17 (2023)
Shingo Nakayamada, Yoshiya Tanaka
Immune Phenotype as a Biomarker for Systemic Lupus Erythematosus. Biomolecules 13 (6) (2023)
Christina Yap, Olga Solovyeva, Johann S de Bono, Jan Rekowski, Dhrusti Patel, Thomas F Jaki, Adrian P Mander, Thomas R Jeffry Evans, Richard Wilson Peck, Kathryn S Hayward, Sally Hopewell, Moreno Ursino, Khadija Rerhou Rantell, Melanie Jane Calvert, Shing Lee, Andrew Kightley, Deborah Ashby, An-Wen Chan, Elizabeth Garrett-Mayer, John Dudley Isaacs, Robert Golub, Olga Kholmanskikh, Dawn P Richards, Oliver Boix, James Matcham, Lesley Seymour, Susan Percy Ivy, Lynley V Marshall, Antoine Hommais, Rong Liu, Yoshiya Tanaka, Jordan D Berlin, Aude Espinasse, Munyaradzi Dimairo, Christopher J Weir
Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance. BMJ (Clinical research ed.) 383 (2023)
Satoshi Kubo, Shingo Nakayamada, Yoshiya Tanaka
JAK inhibitors for rheumatoid arthritis. Expert opinion on investigational drugs (2023)
Yoshiya Tanaka, Peter C Taylor, Emon Elboudwarej, Angie Hertz, Xiaorong Shao, Vladislav A Malkov, Hironori Matsushima, Kahaku Emoto, Bryan Downie, Tsutomu Takeuchi
Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate. Rheumatology and therapy (2023)
Tsutomu Takeuchi, Yukihiro Chino, Masafumi Kawanishi, Megumi Nakanishi, Hirotaka Watase, Yoko Mano, Yuri Sato, Saeko Uchida, Yoshiya Tanaka
Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα NANOBODY ® compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials. Arthritis research & therapy 25 (1) (2023)

Yoshiya Tanaka.css-eqlu8i{font-size:small;padding-left:4px;} (Shigeru Iwata, Y Tanaka)

Publication Activity (10 Years)

Top Topics

Top Venues

Yoshiya Tanaka (Shigeru Iwata, Y Tanaka)